10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001104659-19-064226`
Period End Date	20190930
Filing Date	20191114
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	bpth-20190930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 36 Cash Flow Statement 46 Stockholders Equity 27

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$1.00M	USD	Point-in-time
Cash	`Cash`	$15.38M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$332.00K	USD	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$765.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$739.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$803.00K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$16.89M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.14M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	680,000.00	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	2.88M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	2.88M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.03M	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$998.00K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	680,000.00	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$592.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$708.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$406.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$321.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$388.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Total Assets	`Assets`	$2.54M	USD	Point-in-time
Total Assets	`Assets`	$17.59M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$587.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$522.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$618.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$740.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$79.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.33M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.22M	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$352.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.33M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.57M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 2,884 and 680 shares issued and outstanding, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 2,884 and 680 shares issued and outstanding, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$48.96M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$69.97M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-53.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-47.74M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.99M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$17.91M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.07M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$16.02M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.22M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.74M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$2.54M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$17.59M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$4.10M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.38M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.30M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.34M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$740.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.58M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.98M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$896.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.68M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$3.08M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.28M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$2.27M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-6.28M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.27M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-6.68M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-3.08M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$29.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$70.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$6.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$6.00K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$1.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$29.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$70.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.67M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.21M	USD	3 Qtrs
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-0.78	USD	1 Quarter
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-2.51	USD	3 Qtrs
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-5.38	USD	1 Quarter
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-11.73	USD	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.47M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	573,000.00	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	569,000.00	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.87M	shares	1 Quarter

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.67M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.21M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$416.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$522.00K	USD	3 Qtrs
Amortization of technology license	`AmortizationOfIntangibleAssets`	-	USD	3 Qtrs
Amortization of technology license	`AmortizationOfIntangibleAssets`	$121.00K	USD	3 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetsAmortization`	$75.00K	USD	3 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetsAmortization`	-	USD	3 Qtrs
Depreciation	`Depreciation`	$116.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$198.00K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$433.00K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$-860.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-64.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-72.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-187.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$166.00K	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$63.00K	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	-	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.84M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.12M	USD	3 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	3 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$17.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$19.41M	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.18M	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$900.00K	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.50M	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$17.00M	USD	Point-in-time
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	-	USD	3 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	$1.08M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.18M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.49M	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.68M	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$14.38M	USD	3 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.00M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.38M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.29M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.96M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.00M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.38M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.29M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.96M	USD	Point-in-time
Non-cash leasehold improvements	`NonCashLeaseholdImprovements`	$-31.00K	USD	3 Qtrs

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$2.99M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$17.91M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$8.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$16.02M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$1.22M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$4.74M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$1.18M	USD	1 Quarter
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$1.18M	USD	3 Qtrs
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$1.70M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$19.41M	USD	3 Qtrs
Issuance of common stock, net of fees (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	648,233.00	shares	Point-in-time
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$169.00K	USD	1 Quarter
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$1.08M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$153.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$416.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$184.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$522.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.67M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.21M	USD	3 Qtrs
Ending Balance	`StockholdersEquity`	$2.99M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$17.91M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$8.07M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$16.02M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$1.22M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$4.74M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.